Present Title & Affiliation
- Medical Oncologist, Hospital Israelita Albert Einstein, São Paulo, Brazil
- Coordinator, Sarcoma Tumor Board
- Project Leader, Center of Excellence in Precision Medicine for Sarcoma
- Chair, Sarcoma Research Group — LACOG
- Member, Sarcoma Group — Brazilian Society of Clinical Oncology (SBOC)
| Institution | Role | Notes | |||
|---|---|---|---|---|---|
Current Practice | |||||
Hospital Israelita Albert Einstein, São Paulo, Brazil
| Medical Oncologist | Sarcoma & GI cancers, clinical research | |||
| Coordinator | Sarcoma Tumor Board | ||||
| Project Leader | Precision Medicine for Sarcoma – Center of Excellence | ||||
Latin America Cooperative Oncology Group (LACOG)
| Chair | Sarcoma Research Group | |||
Sociedade Brasileira de Oncologia Clínica (SBOC)
| Member | Sarcoma Group | |||
Education & Training | |||||
PhD
| Faculdade Israelita em Ciências da Saúde Albert Einstein | Biomarker-matched therapies in sarcoma; Published in Clinical Cancer Research | |||
Master in Musculoskeletal Tumors
| Universidad Europea de Madrid / GEIS | Mentored by Dr. Cesar Serrano; TFM published in Frontiers in Oncology | |||
Medical Oncology Fellowship
| MD Anderson Cancer Center, USA | Early-phase oncology exposure | |||
Internal Medicine Residency
| Hospital das Clínicas, University of São Paulo | Clinical training | |||
Visiting Research Graduate Assistant
| Weil Cornell Medicine, NY | IL-6/MMP-9 immunology project → Journal of Immunology | |||
Medical Degree (MD)
| Faculdade de Ciências Médicas da Santa Casa de São Paulo | Completed full medical program | |||
Awards & Scholarships | |||||
ESMO Sarcoma & Rare Cancers Travel Award
| ESMO | ||||
Young Leadership Development Program
| Academia Nacional de Medicina | ||||
Perfect Score — ASCO In-Training Exam
| ASCO | ||||
Presidential Poster of Distinction
| AASLD Liver Meeting | ||||
Session Winner
| International Student Congress of (Bio) Medical Sciences | ||||
Scholarship in Medical Ethics
| Regional Medical Council – São Paulo | ||||
Editorial & Scientific Roles | |||||
| Translational Oncology (IF 4.2) | ||||
H-index
| 19 (Google Scholar) / 15 (Scopus) | ||||
Selected Publications | |||||
Rare Cancers & Sarcoma Policy in Latin America — LACOG report
| JCO Global Oncology, 2025 | ||||
Challenges & Opportunities for Sarcoma in LATAM
| Lancet Regional Health – Americas | ||||
Biomarker-Matched Therapies in Early Trials (SAMBA 101)
| Clinical Cancer Research, 2023 | ||||
Histology-Agnostic Sarcoma Targets
| Frontiers in Oncology, 2023 | ||||
| Clinical Cancer Research, 2023 | ||||
| JCO, 2022 | ||||
Tissue-Agnostic Approvals for Sarcoma
| Trends in Cancer, 2022 | ||||
Antibody-Drug Conjugates Overview
| CA Cancer J Clin, 2022 | ||||
Sarcoma RNA-seq Therapeutic Targets
| Sarcoma RNA-seq Therapeutic Targets Current Problems in Cancer, 2021 | ||||
Immune Markers in Sarcoma
| Cancers, 2021 | ||||
| Nat Rev Clin Oncol, 2020 | ||||
Precision Oncology in Sarcoma
| JCO Precision Oncology, 2019 | ||||
Immunologic Correlates of HCC Response
| Cancer Immunol Res, 2019 | ||||
Antibiotic Use & Immunotherapy Outcomes
| Annals of Oncology, 2018 | ||||
Certifications | |||||
| Brazilian Society of Clinical Oncology | ||||
ECFMG Certification
| |||||